KIORA PHARMACEUTICALS, INC. (KPHMW)

Every figure this model derived for KPHMW, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 107,068 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 16,838,527 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 21,262,515 AssetsCurrent 2026-06-30
current liabilities 2,370,495 LiabilitiesCurrent 2026-06-30
equity 16,856,689 StockholdersEquity 2026-06-30
interest expense 19,960 InterestExpenseNonoperating 2025-12-31
ocf -8,506,810 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 0 Revenues 2025-12-31
sbc 807,666 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up KPHMW on one particular measure came for.

RatioValue
current ratio8.97
current ratio reported8.97
deferred revenue growth-100.0
dilution pct-0.51
growth cv11.6
interest cover-642.71
revenue growth-100.0
revenue growth per share-100.0
roic-55800.61

What to be careful about

What this model itself distrusts about KPHMW's figures. Written by the derivation as it ran, not added afterwards.